New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
09:31 EDTTLOGTetraLogic has new opportunities, says Needham
Needham believes that TetraLogic's Phase I study of birinapant in patients chronically infected with hepatitis B opens up new opportunities for the company. The firm expects the stock to be boosted by data, expected in Q3, from a Phase I/II study in combination with a TRAIL receptor agonist in breast cancer. The firm keeps a Buy rating on the shares.
News For TLOG From The Last 14 Days
Check below for free stories on TLOG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for TLOG

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use